Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2014

Methes Energies International Ltd. (MEIL) Inks Agreements for Over $6 Million of Biodiesel Supply

Today before the opening bell, renewable energy company Methes Energies reported its finalization of agreements with U.S.-based clients to supply them with more than $6 million worth of biodiesel by September 30, 2014. The amount includes Methes Energies’ portion of … Continue reading

Posted in Methes Energies International MEIL | Leave a comment

Methes Energies International Ltd. (MEIL) Meets Regulatory Specification to Produce, Market B100 Pure Biodiesel

Biodiesel is a domestically produced, non-toxic, clean-burning, renewable alternative to petroleum diesel. In a conventional petroleum diesel engine, biodiesel significantly reduces tailpipe emissions of a range of harmful emissions, making it an increasingly viable option for transportation fuel, among other … Continue reading

Posted in Methes Energies International MEIL | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Expands IP Portfolio, Awarded Canadian Patent Coverage

VistaGen Therapeutics, a biotech company using proprietary pluripotent stem cell technology for drug rescue and regenerative medicine, has received from the Canadian Intellectual Property Office a Notice of Allowance for Canadian patent No. 2,684,022, entitled “Mesoderm and Definitive Endoderm Cell … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Feel Empowered to Make that Trade with TradePower.com

Purchasing stock confidently requires the right knowledge. As Francis Bacon, the father of the scientific method once stated, “Knowledge is power.” In mankind’s agricultural past, ownership of land and property meant power. During the Industrial Revolution, ownership of factories and … Continue reading

Posted in Small Cap News | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Stands to Reverse Tremendous Costs of Drug Failure with Pluripotent Stem Cell Technology

For 16 years, California-based VistaGen Therapeutics has worked with key collaborators to develop proprietary technologies which produce several types of several types of mature, functional adult human cells for drug rescue application. In its drug rescue model, the company leverages … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Volt Information Sciences, Inc. (VISI) Narrows Q2 Loss, Staffing Services Segment Drags Revenues Lower

 Volt Information Sciences, an international provider of staffing services and workforce solutions, today posted its Q2 results, showing year-over-year improvements in profitability and a decrease in revenues. The company recorded a Q2 loss of $3.5 million, or $0.17 per share, … Continue reading

Posted in Small Cap News | Leave a comment

MissionSMR Leverages Social Technology to Provide Clients with a Powerful, Successful and Radical Outreach Platform

The applications for social technology in the corporate world are moving at warp speed. Once a means of entertainment, e-mail access and online shopping, social technology has become so entrenched within global businesses, that it is unarguably one of the … Continue reading

Posted in Small Cap News | Leave a comment

Methes Energies International Ltd. (MEIL) Well Positioned in U.S. Biofuel Market Ahead of New EPA Guidelines

Methes Energies, which has long since mastered comprehensive feedstock-driven RIN (Renewable Identification Number) tracking and documentation for EPA, IRS and LCFS (Low Carbon Fuel Standard) compliance, even creating their own proprietary biofuel-centric accounting and logistics software platform to support this … Continue reading

Posted in Methes Energies International MEIL | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Drug Rescue Programs Seen as Viable Solution to Derailed Drug Candidate Development

VistaGen Therapeutics is a stem cell company which centers its attention on drug rescue and regenerative medicine – a type of tissue engineering and molecular biology that deals with the process of replacing, engineering or regenerating human cells, to restore … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Orbit International Corp. (ORBT) Power Group Obtains New Follow-On Orders for $770,000+

Today before the opening bell, Orbit International reported its Orbit Power Group, through its subsidiary Behlman Electronics, Inc., had received new follow-on orders valued at over $770,000. The first order is for a COTS power supply, which is tied to … Continue reading

Posted in Small Cap News | Leave a comment